my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
CyGenics Ltd signed an agreement with the Blood Centre of Zhejiang Province (ZBC) in China for development work generating human T cells outside the body for the treatment of HIV, using CyGenics' proprietary cellular growth technology. This cellular growth technology is owned by CyGenics' wholly own more
CyGenics Ltd. announced Indonesia's pharma company, Kalbe Farma, has taken a 49% stake in its cord blood banking subsidiary, CordLife Indonesia. According to the company, this is a further, important step in CyGenics strategy of focusing on its core business of tissue and cord blood banking, and gre more
CyGenics Ltd. announced that it had disposed of its wholly owned subsidiary, Cell Sciences Pte Ltd, in exchange for a 20% equity in DNAPro Sdn Bhd. Cell Sciences is primarily a distributor of various medical and research products. DNAPro is a Malaysian company engaged in manufacturing and trading bi more
Watchlist
This is where you can add this topic to your personal favourites
About CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2012 CHEMIE.DE Information Service GmbH, All rights reserved
